The Recovering Engineer
FEBRUARY 27, 2010
There are parts of the problem that aren’t addressed by the health care bills under consideration (most egregiously the ridiculous prices charged for pharmaceuticals), but all of the parts being addressed are parts of the problem, while the quality of care itself frankly isn’t. Most of my older posts can be found at.
The Recovering Engineer
FEBRUARY 27, 2010
There are parts of the problem that aren’t addressed by the health care bills under consideration (most egregiously the ridiculous prices charged for pharmaceuticals), but all of the parts being addressed are parts of the problem, while the quality of care itself frankly isn’t. Most of my older posts can be found at.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
OCTOBER 22, 2013
When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. With this in mind, we started to document and study the best-in-class skills of our client companies and their intrapreneurs.
Harvard Business Review
AUGUST 17, 2012
But there's an additional, perhaps less obvious contributor to their success: Cipla has built up a portfolio of skills and resources in a wide variety of highly targeted ways. In the US, Cipla sells its products generic pharmaceutical companies such as Teva and Eagle. to develop and produce an improved first? laç Ticaret Anonim ?irketi
Harvard Business Review
SEPTEMBER 19, 2013
Re-skilling the workforce. They range from Ashoka , which deploys 3,000 citizen changemakers in 70 countries, to the global pharmaceutical giants that annually give away billions of dollars in medicine to low-income citizens. Rising obesity. Human Trafficking. Whose job is it to solve these problems? Consider just a few data points.
Harvard Business Review
JUNE 16, 2011
Ask a buy-side analyst why Amazon or Apple fetches the price-earnings multiple they do, and inevitably the conversation turns to things like their ability to innovate, their capacity to capture and grow the best talent, their skill at managing brand and vendor relationships or ecosystems.
Harvard Business Review
AUGUST 17, 2015
After 2009, the Cuban economy really didn’t recover. It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. pharmaceutical company could be a great asset in the future. It turns incentives about acquiring skills upside down.
Expert insights. Personalized for you.
102 
Let's personalize your content